Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01138085
Title Safety, Pharmacokinetics (PK) of AKT and MEK Combination
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST